CRP and hydrops fetalis: In the overall cohort, patients with hs-CRP levels above the median exhibited significantly higher rates of all-cause mortality (15.9% vs. 10.7%, p < 0.001) and the composite outcome of 6-month death or HF readmission (30.6% vs. 24.2%, p < 0.001).